Urinary incontinence in women is a widespread disease . In recent years, significant progress in its treatment was achieved. Despite this, the mechanisms of continence are still poorly understood.
View Article and Find Full Text PDFSolifenacin at a dose of 5 mg per day has demonstrated the high efficacy in the treatment of patients with overactive bladder. However, for patients who remained dissatisfied with the outcome of treatment, the dose may be increased to 10. mg per day, which leads to the improvement of patient's condition.
View Article and Find Full Text PDFThe study presents an analysis of the experience of treatment of urinary incontinence in women using free synthetic suburethral sling. Between 2001 and 2008, 1081 patients underwent surgery. Of these, 841 (77.
View Article and Find Full Text PDFWe studied prophylactic potential of local use of estriol in respect of urinary infections (UI) in postmenopausal women with asymptomatic bacteriuria (AB) suffering from type 2 diabetes mellitus (DM). A two-stage trial has been conducted. Stage one (a prospective study) was made to detect AB in DM women with AB.
View Article and Find Full Text PDF